COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infection that may break the healthcare system of several countries. Here, we aimed at presenting a critical view of ongoing drug repurposing efforts for COVID-19 as...

Full description

Bibliographic Details
Main Authors: Mario Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas, Marcos Vinicius da Silva Santana, Luiz Carlos Saramago Gonçalves, Lauro Ribeiro de Souza Neto, Sabrina Baptista Ferreira, Floriano Paes Silva-Junior
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ)
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
COVID-19
SARS-CoV-2
drug repurposing
drug discovery
replication cycle
drug targets
Online Access:http://www.scielo.br/pdf/mioc/v115/1678-8060-mioc-115-e200254.pdf

Internet

http://www.scielo.br/pdf/mioc/v115/1678-8060-mioc-115-e200254.pdf

Similar Items